Nu Skin
A global direct-selling company specializing in skincare, beauty devices, personal care, and nutritional supplements.
Last updated October 6, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Nu Skin Enterprises, Inc. is a United States-based direct-selling and multilevel marketing company whose principal activities are the development, manufacture, marketing, and sale of skincare, personal-care, beauty-device, and nutritional products. The company operates primarily through the Nu Skin and Pharmanex brands and reaches customers through a network of independent distributors, who may sell products directly, introduce customers to the brand, and qualify for compensation connected to product sales and the performance of their sales organizations. The company was founded in Utah in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund. Its initial proposition emphasized skincare made with natural ingredients and promoted the idea of retaining beneficial ingredients while excluding unnecessary fillers. After beginning in the United States, Nu Skin expanded to Canada in 1990 and entered Asia through Hong Kong in 1991. The company completed an initial public offering on the New York Stock Exchange in 1996, where its shares trade under the symbol NUS. Nu Skin broadened beyond topical skincare through the 1998 acquisition of Generation Health, the parent of Pharmanex, a nutritional-supplement business. Pharmanex became an important part of the group’s nutrition portfolio and was associated with tools such as the BioPhotonic Scanner, which measures skin carotenoid levels and was used in the company’s product-marketing and wellness programs. Nu Skin later invested in genomics research through LifeGen Technologies, beginning a relationship in 2009 and acquiring the company in 2011. Nu Skin has said that LifeGen’s research and genetic database supported product development and helped inform the ageLOC platform. The brand’s principal commercial areas include anti-aging skincare, cleansing and treatment devices, color cosmetics, body-care products, dietary supplements, and weight-management products. Its ageLOC franchise is positioned around age-related skincare and wellness research, while Pharmanex covers nutritional products. Product development has increasingly combined topical formulations with connected or electronically assisted devices, including the ageLOC LumiSpa iO and Nu Skin RenuSpa iO. The company has also introduced products under Nutricentials, Nu Colour, and MYND360. Nu Skin’s business model and marketing practices have attracted regulatory scrutiny in several periods. In the early 1990s, multiple U.S. states investigated claims concerning distributor earnings and promotional practices. The company reached settlements and agreed to revise promotional practices without admitting wrongdoing. It later entered agreements with the Federal Trade Commission concerning deceptive or unsupported product claims. The company’s Chinese operations also faced criticism and government action, including a 2014 fine related to illegal sales practices and product claims. In 2016, Nu Skin agreed to a class-action settlement concerning disclosures about the registration status of its Chinese subsidiary and separately paid a penalty to the U.S. Securities and Exchange Commission regarding allegations involving charitable funds and a Chinese official. Nu Skin remains headquartered in Provo and continues to operate as a publicly traded global direct-selling company. Its business has expanded beyond traditional product distribution through the Rhyz innovation and investment platform, which acquired social-commerce company Mavely in 2021 and skincare company BeautyBio in 2023. In 2025, Rhyz sold the Mavely platform to Later, a Summit Partners company, in a reported transaction valued at $250 million. The company’s current positioning combines premium beauty and wellness products, scientific and technology-oriented product narratives, and a distributor-led route to market.
History
Nu Skin was established in 1984 in Provo, Utah, by Blake Roney, Sandie Tillotson, and Nedra Roney. The founders built the business around personal-care products marketed through independent distributors rather than through a conventional chain of retail stores. The brand’s early identity emphasized skincare and personal care positioned as more sophisticated than ordinary mass-market products, while its compensation system gave distributors an incentive to develop customer relationships and sales organizations. During the late 1980s and 1990s, Nu Skin expanded its product range and geographic reach. Its business developed from a primarily United States operation into an international direct-selling group with activities in Asia, North America, Europe, and Latin America. The company also broadened its offer beyond topical cosmetics. Nutritional supplements became a major category, including products associated with the Pharmanex business, while weight-management and lifestyle products expanded the company’s wellness proposition. Nu Skin became publicly traded during the 1990s. Public-company status provided access to capital and increased disclosure obligations, but it also subjected the business model and its public claims to continuing scrutiny from investors, regulators, and consumer advocates. Like other direct-selling companies, Nu Skin had to manage the tension between retail product sales and distributor recruitment. Its compliance framework and compensation-plan rules became important parts of its operating model, particularly as the company entered markets with detailed restrictions on direct selling and pyramid schemes. The company’s product strategy increasingly focused on anti-aging science and branded platforms. ageLOC became a central skincare concept, linking multiple products to the company’s claims about the appearance of aging. Nu Skin also developed device-led routines, most notably LumiSpa, and continued to sell facial, body, hair, oral-care, and personal-care products. The combination of consumable products and devices encouraged recurring use and gave distributors demonstrable products for presentations and customer consultations. Asia became a particularly important region for Nu Skin. The company operated in markets including Japan, South Korea, Southeast Asia, and Greater China, each with different requirements for cosmetics, supplements, advertising, product registration, and direct selling. China was especially sensitive because direct-selling activity is closely regulated and because sales structures that authorities view as recruitment-driven can create serious legal exposure. In 2014, Chinese media reports and regulatory attention alleged problems involving Nu Skin’s sales practices and distributor behavior. Chinese authorities investigated the company, and the episode led to negative publicity, operational restrictions, and significant investor concern. Nu Skin stated that it cooperated with the investigation and took steps to review compliance and market practices. The controversy became one of the defining events in the company’s public history because it highlighted the risks of applying a global direct-selling model in a tightly regulated market. In the following years, Nu Skin continued to invest in skincare, beauty technology, nutrition, digital selling tools, and international market development. Leadership changed over time, including the appointment of Ryan Napierski as chief executive officer in 2021. The company has continued to operate as a public direct-selling enterprise headquartered in Provo, while managing changing consumer preferences, distributor engagement, online commerce, foreign-exchange exposure, product regulation, and scrutiny of earnings and marketing claims. Nu Skin’s historical significance lies in its combination of a consumer-facing beauty and wellness portfolio with a large independent-distributor network. Its evolution reflects the broader development of global direct selling: the movement from traditional demonstrations and personal referrals toward social commerce and digital tools, while retaining the regulatory and reputational challenges associated with distributor compensation and product claims.
- 2021
Ryan Napierski becomes chief executive officer
[3]Ryan Napierski succeeds Truman Hunt as chief executive officer.
- 2014
China regulatory controversy
[2]Chinese authorities investigate allegations related to Nu Skin’s direct-selling and distributor practices, creating major reputational and market pressure.
- 1996
Nu Skin becomes publicly traded
[1]Nu Skin Enterprises becomes a public company and trades on the New York Stock Exchange under the symbol NUS.
- 1990
International expansion begins
[1]Nu Skin expands its direct-selling operations beyond the United States, beginning a long-term international growth strategy.
- 1984
Nu Skin is founded in Utah
[1]Blake Roney, Sandie Tillotson, and Nedra Roney establish the company in Provo, Utah, with a direct-selling focus on personal-care products.
Products and positioning
Mid-to-high-end anti-aging skincare and wellness products distributed primarily through direct selling, with an emphasis on cosmetic science, beauty devices, nutritional supplementation, and personalized routines.
Anti-aging skincare platform
ageLOC
ageLOC is Nu Skin’s principal anti-aging skincare platform. It has been used across facial and body-care products and is marketed around routines intended to improve the appearance of visible aging. The range has included cleansers, serums, moisturizers, masks, and products designed to work with Nu Skin beauty devices. Its importance is both commercial and brand-building: the platform gives the company a common science-and-technology narrative across multiple skincare categories.
Facial cleansing and beauty device
LumiSpa
LumiSpa is a Nu Skin facial device system combining a handheld device with specially formulated cleansing products. It is positioned as a daily skincare routine intended to cleanse and polish the skin while providing a device-based experience that can be demonstrated by distributors. The system extends Nu Skin beyond conventional creams and lotions and supports recurring sales of compatible consumable products.
Nutritional supplements
Pharmanex
Pharmanex is the nutritional-supplement and wellness brand associated with Nu Skin. Its portfolio has included vitamins, minerals, botanical products, and other dietary supplements. Products are marketed through the company’s direct-selling network and are subject to country-specific rules governing ingredients, health claims, labeling, and product registration. Pharmanex broadens Nu Skin’s business from topical beauty into ingestible wellness.
Weight-management and lifestyle program
TR90
TR90 is Nu Skin’s weight-management and lifestyle-oriented product platform. It has included nutritional products and structured programs intended to support weight-management goals. The line complements the company’s skincare and supplement businesses, while its marketing must operate within local restrictions on nutrition, health, and weight-loss claims.
Controversies
2014
China direct-selling investigation
Chinese authorities investigated allegations concerning Nu Skin’s sales practices and distributor activity. The episode generated extensive negative publicity, disrupted the company’s China operations, and caused substantial investor concern. It also highlighted the compliance risks faced by international direct-selling companies in China.
Brand decisions
2021
Leadership transition to Ryan NapierskiStrategyBackground
Nu Skin sought to develop its product portfolio and modernize distributor engagement as direct selling increasingly incorporated digital and social-commerce tools.
Action taken
Ryan Napierski became chief executive officer, succeeding Truman Hunt.
Aftermath
The company continued emphasizing skincare innovation, beauty devices, nutritional products, and digital support for its global sales network.
2014
Review of China operations and compliance practicesStrategyBackground
Regulatory scrutiny and media allegations raised questions about distributor conduct and the operation of Nu Skin’s direct-selling model in China.
Action taken
Nu Skin stated that it cooperated with authorities, reviewed its practices, and adjusted aspects of its China operations and compliance approach.
Aftermath
The controversy reduced confidence in the company’s China growth outlook and made regulatory and market risk a central issue in its public disclosures.
Recent events
Nu Skin adds two board members[4]
Reported:
Nu Skin Enterprises announced that shareholders elected Ryan S. Napierski and Emma S. Battle to serve on its Board of Directors.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/nu-skin · Editorial policy · How profiles are compiled